Microbix Biosystems Inc logo

Microbix Biosystems Inc

OTCPK:MBXBF (Canada)  
$ 0.25 -0.003045 (-1.22%) 10:08 PM EST
11.75
P/B:
1.64
Market Cap:
$ 33.91M
Enterprise V:
$ 29.13M
Volume:
3.30K
Avg Vol (2M):
10.73K
Also Trade In:
Volume:
3.30K
Avg Vol (2M):
10.73K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for MBXBF ( Microbix Biosystems Inc ) from 1990 to Jun 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Microbix Biosystems stock (MBXBF) PE ratio as of Jun 11 2024 is 11.75. More Details

Microbix Biosystems Inc (MBXBF) PE Ratio (TTM) Chart

To

Microbix Biosystems Inc (MBXBF) PE Ratio (TTM) Historical Data

Total 1245
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Microbix Biosystems PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-11 11.8 2024-04-08 13.2
2024-06-10 11.8 2024-04-05 13.2
2024-06-07 11.9 2024-04-04 13.3
2024-06-06 11.9 2024-04-03 13.4
2024-06-05 11.9 2024-04-02 13.6
2024-06-04 11.4 2024-04-01 13.6
2024-06-03 11.6 2024-03-28 13.3
2024-05-31 11.6 2024-03-27 14.7
2024-05-30 11.6 2024-03-26 14.7
2024-05-29 11.6 2024-03-25 14.7
2024-05-28 11.6 2024-03-22 14.5
2024-05-24 11.3 2024-03-21 14.5
2024-05-23 11.4 2024-03-20 14.5
2024-05-22 11.6 2024-03-19 15.0
2024-05-21 11.6 2024-03-18 15.3
2024-05-20 12.2 2024-03-15 15.3
2024-05-17 12.2 2024-03-14 15.3
2024-05-16 12.2 2024-03-13 15.3
2024-05-15 12.3 2024-03-12 15.3
2024-05-14 11.8 2024-03-11 15.0
2024-05-13 11.7 2024-03-08 15.0
2024-05-10 11.7 2024-03-07 15.0
2024-05-09 11.7 2024-03-06 15.0
2024-05-08 11.7 2024-03-05 15.0
2024-05-07 11.7 2024-03-04 15.8
2024-05-06 11.7 2024-03-01 15.8
2024-05-03 11.7 2024-02-29 15.9
2024-05-02 11.7 2024-02-28 15.9
2024-05-01 11.7 2024-02-27 15.9
2024-04-30 11.7 2024-02-26 15.9
2024-04-29 11.7 2024-02-23 15.9
2024-04-26 11.7 2024-02-22 15.3
2024-04-25 11.9 2024-02-21 16.6
2024-04-24 11.9 2024-02-20 16.6
2024-04-23 11.9 2024-02-16 16.6
2024-04-22 11.9 2024-02-15 16.6
2024-04-19 12.3 2024-02-14 17.1
2024-04-18 12.3 2024-02-13 15.1
2024-04-17 12.3 2024-02-12 15.1
2024-04-16 12.3 2024-02-09 15.1
2024-04-15 12.4 2024-02-08 15.1
2024-04-12 12.9 2024-02-07 14.5
2024-04-11 12.9 2024-02-06 14.5
2024-04-10 13.0 2024-02-05 15.6
2024-04-09 13.0 2024-02-02 15.6

Microbix Biosystems Inc (MBXBF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.